Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of reslizumab to treat moderate to severe eosinophilic asthma

Use of reslizumab to treat moderate to severe eosinophilic asthma

US Patent 10577414 · Granted Mar 3, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treating inflammatory bowel disease with a combination therapy of anti2025
Method of treating inflammatory bowel disease with a combination therapy of anti2023
Methods for the administration of certain VMAT2 inhibitors2023
Methods for the administration of certain VMAT2 inhibitors2022
High dosage valbenazine formulation and compositions, methods, and kits related 2022
Methods for the administration of certain VMAT2 inhibitors2021
Methods for the administration of certain VMAT2 inhibitors2021
Methods for the administration of certain VMAT2 inhibitors2021
Methods of treating moderately to severely active ulcerative colitis by administ2021
Methods for the administration of certain VMAT2 inhibitors2021
Methods for the administration of certain VMAT2 inhibitors2021
Methods for the administration of certain VMAT2 inhibitors2020